Dr. Wierman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Summary
- Dr. Margaret Wierman is an endocrinologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, Veterans Affairs Eastern Colorado Health Care System, UCHealth Memorial Hospital, and UCHealth Poudre Valley Hospital. She received her medical degree from Baylor College of Medicine and has been in practice 38 years. She specializes in reproductive medicine and endocrine tumors including pituitary tumors and adrenal cancer. .
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1985 - 1985
- Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1983
- Baylor College of MedicineResidency, Internal Medicine, 1979 - 1982
- Baylor College of MedicineClass of 1979
Certifications & Licensure
- CO State Medical License 1987 - 2025
- TX State Medical License 1979 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- President International Society of Endocrinology, 2020, 2022
- Regional Top Doctor Castle Connolly, 2014
- Vice President, Clinical Scientist The Endocrine Society, 2012
- Join now to see all
Clinical Trials
- Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
- Bioenergetic Effects of Aging and Menopause (BEAM) Start of enrollment: 2019 Sep 24
Roles: Sub-Investigator
Publications & Presentations
PubMed
- Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway.Chitra Subramanian, Kelli McNamara, Seth W Croslow, Yanqi Tan, Daniel Hess
Surgery. 2025-01-01 - A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.Yasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, Prashant Khandagale, Ukhyun Jo
Cancer Research Communications. 2024-09-01 - Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.Katia Mariniello, James F H Pittaway, Barbara Altieri, Kleiton Silva Borges, Irene Hadjidemetriou
Biorxiv. 2024-08-22
Lectures
- Testosterone Therapy: Optimizing Benefits and Minimizing RiskENDO 2019 - New Orleans, LA - 3/24/2019
- Early Career ForumENDO 2019 - New Orleans, LA - 3/22/2019
- Testosterone Therapy: Optimizing Benefits and Minimizing Risk (Repeat)`ENDO 2019 - New Orleans, LA - 3/24/2019
- Join now to see all
Press Mentions
- Targeting Patients with Pellets: A Look at Biodentical HormonesOctober 8th, 2019
- Try Testosterone for Some Women with Sexual Dysfunction, but Not OthersSeptember 11th, 2019
- Try Testosterone Only in Women with Hypoactive Sexual DesireNovember 21st, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: